Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| ZE5-V5221 | Ebolavirus | Ebolavirus EBOV (subtype Zaire, strain Kikwit-95) Envelope Glycoprotein (GP) Protein, His Tag |  |
|
|
| BEP-V5220 | Ebolavirus | Ebolavirus BDBV (subtype Bundibugyo, strain Uganda 2007) Small/secreted Glycoprotein (sGP) Protein, His Tag |  |
|
|
| ZE5-V5220 | Ebolavirus | Ebolavirus EBOV (subtype Zaire, strain Kikwit-95) Envelope Glycoprotein 1 (GP1) Protein, His Tag |  |
|
|
| BEP-V5221 | Ebolavirus | Ebolavirus (subtype Bundibugyo, strain Uganda 2007) Envelope Glycoprotein 1 (GP1) Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Ansuvimab | VRC-EBOMAB092-00-AB; MAb114; MAb-114 | Approved | National Institute Of Allergy And Infectious Diseases (Niaid), National Institute of Health, Islamabad | Ebanga | United States | Hemorrhagic Fever, Ebola | Ridgeback Biotherapeutics Lp | 2020-12-21 | Hemorrhagic Fever, Ebola | Details |
| Atoltivimab/Maftivimab/Odesivimab | REGN3470-3471-3479; REGN-EB3 | Approved | Inmazeb | United States | Hemorrhagic Fever, Ebola | Regeneron Pharmaceuticals Inc | 2020-10-14 | Hemorrhagic Fever, Ebola | Details | |
| Ansuvimab | VRC-EBOMAB092-00-AB; MAb114; MAb-114 | Approved | National Institute Of Allergy And Infectious Diseases (Niaid), National Institute of Health, Islamabad | Ebanga | United States | Hemorrhagic Fever, Ebola | Ridgeback Biotherapeutics Lp | 2020-12-21 | Hemorrhagic Fever, Ebola | Details |
| Atoltivimab/Maftivimab/Odesivimab | REGN3470-3471-3479; REGN-EB3 | Approved | Inmazeb | United States | Hemorrhagic Fever, Ebola | Regeneron Pharmaceuticals Inc | 2020-10-14 | Hemorrhagic Fever, Ebola | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Porgaviximab/Larcaviximab/Cosfroviximab | c2G4-N; c4G7; c13C6 | Phase 3 Clinical | Mapp Biopharmaceutical, Public Health Agency Of Canada'S National Microbiology Laboratory | Hemorrhagic Fever, Ebola | Details |
| MIL-77 | MIL-77 | Phase 1 Clinical | Beijing Mabworks Biotech Co Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, Institute Of Basic Medicine Academy Of Military Medical Sciences | Hemorrhagic Fever, Ebola | Details |
| Porgaviximab/Larcaviximab/Cosfroviximab | c2G4-N; c4G7; c13C6 | Phase 3 Clinical | Mapp Biopharmaceutical, Public Health Agency Of Canada'S National Microbiology Laboratory | Hemorrhagic Fever, Ebola | Details |
| MIL-77 | MIL-77 | Phase 1 Clinical | Beijing Mabworks Biotech Co Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, Institute Of Basic Medicine Academy Of Military Medical Sciences | Hemorrhagic Fever, Ebola | Details |
This web search service is supported by Google Inc.
A-Z
